Search Filters

Search Results

Found 1810 results

510(k) Data Aggregation

    K Number
    K250040
    Device Name
    uWS-Angio
    Date Cleared
    2025-09-12

    (247 days)

    Product Code
    Regulation Number
    892.2050
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    Shanghai United Imaging Healthcare Co., Ltd.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    Device Description
    AI/ML Overview
    Ask a Question

    Ask a specific question about this device

    K Number
    K252554
    Date Cleared
    2025-09-12

    (30 days)

    Product Code
    Regulation Number
    862.3100
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    VivaChek Biotech (Hangzhou) Co., Ltd

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    Device Description
    AI/ML Overview
    Ask a Question

    Ask a specific question about this device

    Why did this record match?
    Applicant Name (Manufacturer) :

    Fisher & Paykel Healthcare Ltd

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    Device Description
    AI/ML Overview
    Ask a Question

    Ask a specific question about this device

    K Number
    K251891
    Date Cleared
    2025-09-09

    (81 days)

    Product Code
    Regulation Number
    890.3860
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    Shandong Guyue Healthcare Appliance Co., Ltd.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    Device Description
    AI/ML Overview
    Ask a Question

    Ask a specific question about this device

    K Number
    K252608
    Date Cleared
    2025-09-09

    (22 days)

    Product Code
    Regulation Number
    892.2050
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    Siemens Healthcare GmbH

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    Device Description
    AI/ML Overview
    Ask a Question

    Ask a specific question about this device

    K Number
    K251168
    Device Name
    Image Suite
    Date Cleared
    2025-09-04

    (142 days)

    Product Code
    Regulation Number
    892.2050
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    Carestream Health Inc.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    Device Description
    AI/ML Overview
    Ask a Question

    Ask a specific question about this device

    K Number
    K251727
    Date Cleared
    2025-08-29

    (85 days)

    Product Code
    Regulation Number
    878.4810
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    TOUCHBEAUTY BEAUTY & HEALTH (SHENZHEN) CO., LTD

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Red Light is intended to treat full face wrinkles.
    The Blue Light is intended to treat mild to moderate inflammatory acne.
    The Yellow Light is intended to treat wrinkles.

    Device Description

    The GLAM LED light therapy mask is a home use wearable light emitting diode phototherapy device whose purpose is to produce an even, cool, narrow band of light for the treatment of full face wrinkles and mild to moderate acne of the face. The outer shell of the mask is manufactured from Polyethylene terephthalate (PET). The inner shell is a clear Polycarbonate (PC). The Light emitting diodes are mounted behind the clear Polycarbonate. The LEDs generate the light. The ear hooks are made of Acrylonitrile butadiene styrene (ABS) and the silicone goggle protect the eyes from LED lights. Unfold the ear hooks and place the mask on your face, the mask will automatically activate the light therapy mode. The LEDs produce blue, red and yellow light in the visible spectrum (Blue:415nm +/- 10nm, Yellow: 590nm +/-10nm, Red: 625nm +/-10nm.). The device works by emitting the specified wavelengths to treat full face of wrinkles or to treat mild to moderate inflammatory acne. Press the touch switch on the right ear hook twice to select the light therapy mode you want to use. Each mode operates in a 15-minute cycle. After 15 minutes, the device automatically deactivates the light mode and enters the standby mode.

    AI/ML Overview

    This FDA 510(k) clearance letter for the GLAM LED Facial Mask (TB-2386F) does not include any information regarding clinical testing, acceptance criteria for device performance related to efficacy (e.g., wrinkle reduction or acne treatment), or studies comparing the device's performance against such criteria.

    The letter focuses on the substantial equivalence based on:

    • Technological Comparison: Comparing light wavelengths, power density, and treatment time to predicates.
    • Safety Standards Compliance: Verification through non-clinical tests (electrical safety, EMC, biocompatibility, photobiological safety, software verification).

    Therefore, I cannot provide details on the specific acceptance criteria for efficacy or a study proving the device meets those criteria from the provided document. The 510(k) summary explicitly states: "No animal or clinical study is included in this submission."

    However, if we were to hypothesize what acceptance criteria and a study might look like for a device with these indications, and then illustrate what would be missing from this document:

    Hypothetical Acceptance Criteria and Performance Study (Not Found in Provided Document):

    Since the provided document explicitly states no clinical study was included, the following tables and sections represent what would typically be expected for a device claiming therapeutic efficacy, but none of this information is present in the provided 510(k) clearance letter.

    Hypothetical Acceptance Criteria and Reported Device Performance (If Clinical Data Existed)

    Acceptance Criteria (Hypothetical)Reported Device Performance (Hypothetical)
    Red Light (Wrinkle Treatment):
    Primary Endpoint: A statistically significant reduction (e.g., >20%) in the appearance of fine lines and wrinkles (e.g., Fitzpatrick Wrinkle Scale, or qualitative dermatological grading) across the full face after 8-12 weeks of treatment, compared to baseline or a control group.Not reported in 510(k) letter. If available, this section would state the measured percentage reduction in wrinkles, p-values, confidence intervals, and the specific grading scale used. Example: "Mean reduction of 32% in Fitzpatrick Wrinkle Scale scores for fine lines after 10 weeks (p 70% of subjects reporting improvement) in overall skin appearance, texture, or satisfaction as reported by subjects via a validated questionnaire.
    Ask a Question

    Ask a specific question about this device

    K Number
    K252118
    Date Cleared
    2025-08-27

    (51 days)

    Product Code
    Regulation Number
    862.3100
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    Hangzhou Clongene Biotech Co.,Ltd.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The CLUNGENE Multi-Drug Test Easy Cup is a lateral flow immunoassay for the qualitative detection of Morphine, Methamphetamine, Cocaine, Marijuana, Methylenedioxymethamphetamine, Buprenorphine, Propoxyphene, Amphetamine, Phencyclidine, EDDP (Methadone metabolite), Oxycodone, Oxazepam, Nortriptyline, Secobarbital, Methadone, 6-Monoacetylmorphine and Fentanyl in human urine at the following cut off concentrations:

    DrugCalibratorCut-off (ng/mL)
    Morphine (MOP/OPI300)Morphine300
    Morphine (MOP/OPI2000)Morphine2,000
    Methamphetamine (mAMP/MET1000)D-Methamphetamine1,000
    Methamphetamine (mAMP/MET500)D-Methamphetamine500
    Cocaine (COC300)Benzoylecgonine300
    Cocaine (COC150)Benzoylecgonine150
    Marijuana (THC)11-nor-9-THC-9-COOH50
    Methylenedioxymethamphetamine (MDMA)D,L-Methylenedioxymethamphetamine500
    Buprenorphine (BUP)Buprenorphine10
    Propoxyphene (PPX)D-Propoxyphene300
    Amphetamine (AMP1000)D-Amphetamine1,000
    Amphetamine (AMP500)D-Amphetamine500
    Phencyclidine (PCP)Phencyclidine25
    Methadone metabolite (EDDP)2-Ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine300
    Oxycodone (OXY)Oxycodone100
    Oxazepam (BZO)Oxazepam300
    Nortriptyline (TCA)Nortriptyline1,000
    Secobarbital (BAR)Secobarbital300
    Methadone (MTD)Methadone300
    6-Monoacetylmorphine (6-MAM)6-Monoacetylmorphine10
    Fentanyl (FYL)Fentanyl1

    The single or multi-test cups can consist of any combination of the above listed drug analytes, but only one cut off concentration under same drug condition will be included per device.

    This test provides only preliminary result. A more specific alternative chemical method must be used to obtain a confirmed analytical result. GC/MS or LC/MS is the preferred confirmatory method. Evaluate preliminary positive results carefully. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

    The CLUNGENE Multi-Drug Home Test Easy Cup is a lateral flow immunoassay for the qualitative detection of Morphine, Methamphetamine, Cocaine, Marijuana, Methylenedioxymethamphetamine, Buprenorphine, Propoxyphene, Amphetamine, Phencyclidine, EDDP (Methadone metabolite), Oxycodone, Oxazepam, Nortriptyline, Secobarbital, Methadone, 6-Monoacetylmorphine and Fentanyl in human urine at the following cut off concentrations:

    Drug (Identifier)Cut-off (ng/mL)
    Morphine (MOP/OPI2000)300 or 2000
    Methamphetamine (mAMP/MET)500 or 1,000
    Cocaine (COC)150 or 300
    Marijuana (THC)50
    Methylenedioxymethamphetamine (MDMA)500
    Buprenorphine (BUP)10
    Propoxyphene (PPX)300
    Amphetamine (AMP)500 or 1,000
    Phencyclidine (PCP)25
    Methadone metabolite (EDDP)300
    Oxycodone (OXY)100
    Oxazepam (BZO)300
    Nortriptyline (TCA)1,000
    Secobarbital (BAR)300
    Methadone (MTD)300
    6-Monoacetylmorphine (6-MAM)10
    Fentanyl (FYL)1
    The single or multi-test cup offers any combination from above 1 to 17 drugs, but only one cut off concentration under same drug condition will be included per device.

    The test provides only preliminary test results. To obtain a confirmed analytical result, a more specific alternative chemical method must be used. GC/MS or LC-MS/MS is the preferred confirmatory method.

    It is intended for over-the-counter (OTC) use. For in vitro diagnostic use only.

    Device Description

    CLUNGENE Multi-Drug Test Easy Cup and CLUNGENE Multi-Drug Home Test Easy Cup are immunochromatographic assays that use a lateral flow system for the qualitative detection of single or multiple drugs in human urine.
    The device is a cup format. Each test device is sealed with two sachets of desiccant in an aluminum pouch. The device is in a ready-to-use format and no longer requires assembly before use.

    AI/ML Overview

    This document provides details on the performance characteristics of the CLUNGENE Multi-Drug Test Easy Cup and CLUNGENE Multi-Drug Home Test Easy Cup. Since this is an in vitro diagnostic device (specifically, a drug screening test), the acceptance criteria and study design are typically focused on analytical performance (accuracy, precision, analytical specificity) rather than a multi-reader multi-case (MRMC) comparative effectiveness study, which is more common for imaging AI. Similarly, "human readers improving with AI vs without AI" is not applicable here as the device is the test, not an aid to human interpretation of another modality.

    Here's the breakdown based on the provided text:

    Acceptance Criteria and Reported Device Performance

    The core acceptance criterion for qualitative drug screening tests like this is accurate detection around a specific cutoff concentration. The reported performance demonstrates the device's ability to correctly classify samples as positive or negative relative to these cutoffs.

    Table of Acceptance Criteria and Reported Device Performance (Analytical Precision/Reproducibility)

    The "Acceptance Criteria" column represents the desired performance for a qualitative assay around its cutoff. For positive results, this means detecting drug concentrations above the cutoff, and for negative results, it means not detecting concentrations below the cutoff. The provided precision data shows the number of positive (+) and negative (-) results out of 50 tests for various concentrations relative to the cutoff. An ideal performance would show 100% positive for concentrations above cutoff and 100% negative for concentrations below, with roughly 50/50 split at the cutoff itself (due to inherent variability).

    Drug (Cut-off ng/mL)Acceptance Criteria (Implicit for qualitative assay)Reported Device Performance (Accuracy as evidenced by reproducibility at various concentrations) Number of negative/positive results out of 50 tests. Values are aggregated across 3 lots where available.
    MOP300All samples >cutoff should test positive; all samples
    Ask a Question

    Ask a specific question about this device

    K Number
    K250261
    Manufacturer
    Date Cleared
    2025-08-26

    (209 days)

    Product Code
    Regulation Number
    878.4810
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    Heager Gmbh

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Heager Medical Laser Family device is intended for delivery of laser light to soft tissue in the contact and non contact mode during surgical procedures. The device's 980nm laser is generally indicated for use in incision, excision, vaporization, ablation, hemostasis or coagulation of soft tissue in ear, nose and throat and oral surgery (otolaryngology), dental procedures, gastroenterology, general surgery, dermatology, plastic surgery, podiatry, urology, gynecology. The device is further indicated for laser assisted lipolysis. The device's 1470nm laser is intended for delivery of laser light to soft tissue in non-contact mode during general surgery procedures, indicated for the treatment of reflux of the saphenous veins associated with varicose veins and varicosities.

    Device Description

    The Heager Medical Laser Family generates a 980nm wavelength laser to act on a target tissue to achieve hemostasis, ablation, and coagulation of the target tissue. The Heager Medical Laser Family generates a 1470 nm wavelength laser that acts on the water molecules of the target tissue to achieve the function of treatment of reflux of the saphenous veins associated with varicose veins and varicosities.

    The Heager Medical Laser Family has following characteristics:

    • Dual wavelengths
    • Temperature monitoring system
    AI/ML Overview

    This document is a 510(k) clearance letter for a medical laser device, not a study report. Therefore, it does not contain the specific details about acceptance criteria and study results you requested in the format typically found in a clinical or performance study.

    Based on the provided FDA 510(k) clearance letter for the Heager Medical Laser Family, here's what can be extracted and what information is not available within this document:

    1. A table of acceptance criteria and the reported device performance

    The document does not explicitly state acceptance criteria in a quantitative, measurable way for device performance in terms of clinical outcomes or diagnostic accuracy. Instead, it demonstrates substantial equivalence to predicate devices based on technical specifications and adherence to recognized electrical and safety standards.

    The "reported device performance" is primarily presented as technical specifications and compliance with safety standards rather than clinical performance metrics.

    Feature/StandardAcceptance Criteria (Implied)Reported Device Performance
    WavelengthWithin specified range980nm±20nm, 1470nm±20nm
    Laser Output PowerWithin specified range980nm±20nm cw 20W, 1470nm±20nm cw 15W
    Aiming BeamWithin specified rangeDiode laser of 650nm, power Max. 10mW, adjustable brightness
    Pulse Width RangeAppropriately wide for intended use, similar to reference devices0.1s - 10s (stepping 0.1s)
    Electrical SafetyCompliance with IEC 60601-1 ed. 3.2, IEC 60825-1 ed. 2.0, IEC 60601-2-22 ed. 4.0Complies with IEC 60601-1:2005+A1:2012+A2:2020, IEC 60825-1:2014, IEC 60601-2-22:2019 (Note: IEC 60825-1 is listed as ed 2.0 in section 7.0 and 2014 in section 12, need clarification if 2014 is equivalent to or supersedes 2.0)
    Electromagnetic Compatibility (EMC)Compliance with IEC 60601-1-2 ed. 4.1Complies with IEC 60601-1-2:2014+A1:2021
    User Interface (IEC 60601-1-6)Compliance with IEC 60601-1-6 ed. 3.2Complies with IEC 60601-1-6 Edition 3.2 2020-07 CONSOLIDATED VERSION
    Biocompatibility of contact materials (implied for fiber)Compliance with ISO 10993 seriesFibers must meet ISO 10993 series standards

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    This information is not available in the provided document. As this is a 510(k) for a laser surgical instrument, the primary "test set" would be the device itself tested against engineering and safety standards, not a clinical data set in the way an AI/diagnostic device would have. The document explicitly states: "No clinical study implemented for the Diode laser therapy device."

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This information is not available. Given that "No clinical study implemented," there would be no ground truth established by experts in a clinical context for the purpose of a study demonstrating effectiveness. The "ground truth" here is the adherence to engineering standards and technical specifications.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This information is not available. Adjudication methods are typically associated with clinical studies involving human observers or raters, which were not conducted for this 510(k) submission.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This information is not applicable and not available. This is a laser surgical instrument, not an AI software/diagnostic device that would involve human readers or AI assistance in interpretation.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

    This information is not applicable and not available. This is not an algorithm or AI device.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    The "ground truth" in this 510(k) context is primarily compliance with recognized electrical, safety, and performance standards (e.g., IEC standards) and technical specifications of the device, demonstrated through non-clinical testing.

    8. The sample size for the training set

    This information is not applicable and not available. There is no "training set" in the context of an AI/machine learning model for this type of laser device 510(k) submission.

    9. How the ground truth for the training set was established

    This information is not applicable and not available for the same reason as point 8.

    Ask a Question

    Ask a specific question about this device

    Why did this record match?
    Applicant Name (Manufacturer) :

    HARPS Europe Manufacturing GmbH

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Sterile Powder Free Synthetic Rubber Surgeon's Gloves, Green Color, Tested For Use With Chemotherapy Drugs and Gastric Acid is a single use disposable device intended to be worn by operating room personnel to protect a surgical wound from contamination.

    The tested drugs are:

    CompoundMinimum Breakthrough Time (minutes)
    Carmustine (BCNU) (3.3 mg/ml)15.8
    Cyclophosphamide (20 mg/ml)>240
    Doxorubicin (2 mg/ml)>240
    Etoposide (Toposar) (20 mg/ml)>240
    Fluorouracil (50 mg/ml)>240
    Paclitaxel (6 mg/ml)>240
    Thiotepa (THT) (10 mg/ml)24.6
    Bleomycin sulfate (15 mg/ml)>240
    Carboplatin (10 mg/ml)>240
    Cisplatin (1 mg/ml)>240
    Cytarabine (100 mg/ml)>240
    Dacarbazine (10 mg/ml)>240
    Daunorubicin HCl (5 mg/ml)>240
    Docetaxel (10 mg/ml)>240
    Gemcitabine HCl (38 mg/ml)>240
    Idarubicin HCl (1 mg/ml)>240
    Ifosfamide (50 mg/ml)>240
    Irinotecan HCl (20 mg/ml)>240
    Mechlorethamine HCl (1 mg/ml)>240
    Melphalan HCl (5 mg/ml)>240
    Methotrexate (25 mg/ml)>240
    Mitomycin C (0.5 mg/ml)>240
    Mitoxantrone (2 mg/ml)>240
    Vincristine Sulfate (1 mg/ml)>240
    Busulfan (6 mg/ml)>240
    Chloroquine (50 mg/ml)>240
    Cyclosporin A (100 mg/ml)>240
    Epirubicin HCl (2 mg/ml)>240
    Fludarabine Phosphate (25 mg/ml)>240
    Oxaliplatin (2 mg/ml)>240
    Retrovir (10 mg/ml)>240
    Rituximab (10 mg/ml)>240
    Topotecan HCl (1 mg/ml)>240
    Trisenox (Arsenic Trioxide) (1 mg/ml)>240
    Velcade (Bortezomib) (1 mg/ml)>240

    Simulated Gastric Acid Fluid was also tested with a minimum breakthrough greater than 240 minutes.

    Device Description

    Sterile Powder Free Synthetic Rubber Surgeon's Gloves, Green Color, Tested For Use With Chemotherapy Drugs and Gastric Acid is a sterile and disposable device. This glove is made of synthetic polyisoprene rubber inside coated with synthetic material to ease donning the glove. The device is intended to be worn on hands, usually in surgical settings, to provide a barrier against potentially infectious materials and other contaminants. These gloves were tested for use with Chemotherapy Drugs and Gastric Acid as per ASTM D6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

    The device conforms to the following FDA recognized consensus standards: ASTM D3577-19, ASTM D6124-06, ASTM D5151-19, ASTM D412-16, ISO 11137-1:2006 + AMD1:2013 + AMD2:2018, ISO 11137-2:2013 + AMD1:2022, and ASTM D6978-05.

    Sterile Powder Free Synthetic Rubber Surgeon's Gloves, Green Color, Tested For Use With Chemotherapy Drugs and Gastric Acid is available in the following sizes: 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, and 9.0.

    AI/ML Overview

    The provided document is a 510(k) clearance letter from the FDA for a medical device: "Sterile Powder Free Synthetic Rubber Surgeon's Gloves, Green Color, Tested For Use With Chemotherapy Drugs and Gastric Acid." This document outlines the general requirements for the device and details the non-clinical testing performed to establish substantial equivalence to a predicate device.

    However, it does not contain any information regarding clinical studies, AI/ML device performance, or human-in-the-loop studies. The device is a physical medical glove and not an AI-powered diagnostic or assistive tool. Therefore, the requested information elements related to AI/ML and clinical study methodologies are not applicable to this submission.

    The document focuses on demonstrating the physical, chemical, and biological safety and performance of the gloves according to recognized consensus standards.

    Here's the relevant information that can be extracted:

    1. Table of Acceptance Criteria and Reported Device Performance

    The device underwent non-clinical testing against several recognized standards. The "Results" column consistently states "PASS," indicating that the device met the specified acceptance criteria for each test.

    Title of TestPurpose of TestAcceptance CriteriaReported Device Performance
    ASTM D3577-19DimensionsMeets criteria in accordance with ASTM D3577-19: Standard Specification for Rubber Surgical GlovesPASS
    ASTM D3577-19Physical PropertiesMeets criteria for tensile strength, ultimate elongation and stress at 500% elongation before and after accelerated aging for synthetic surgical gloves per ASTM D3577-19: Standard Specification for Rubber Surgical GlovesPASS
    ASTM D5151-19Freedom from holesMeets criteria in accordance with ASTM D3577-19: Standard Specification for Rubber Surgical Gloves with AQL requirements of 0.65PASS
    ASTM D6124Powder-FreeMeets applicable acceptance criteria for powder free ≤ 2mg per glove per ASTM D3577-19: Standard Specification for Rubber Surgical GlovesPASS
    ISO 11137-1:2006SterilityMeets acceptance criteria requirement of 10⁻⁶ SAL per ISO 11137-1: Sterilization for health care products – Radiation – Part 1: Requirements for development, validation and routine control of a sterilization process for medical devicesPASS
    ASTM D6978-05Chemotherapy Drug Permeation TestTesting performed in accordance with ASTM D6978-05: Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs.PASS
    ISO 10993-10:2010Biocompatibility: Skin IrritationPasses Primary Skin Irritation test per ISO 10993-10, Biological Evaluation of medical devices, Part 10: Test for irritation and skin sensitization. Under the conditions of the study, not an irritant.PASS
    ISO 10993-10:2010Biocompatibility: Dermal SensitizationPasses Dermal Sensitization test per ISO 10993-10, Biological Evaluation of medical devices, Part 10: Test for irritation and skin sensitization. Under the conditions of the study, not a sensitizer.PASS
    ISO 10993-11:2017Biocompatibility: Acute Systemic ToxicityPasses Acute Systemic Toxicity Test per ISO 10993-11, Biological Evaluation of medical devices, Part 11: Test for systemic toxicity. Under the conditions of the study, there was no mortality or evidence of acute systemic toxicity.PASS
    ISO 10993-11:2017Biocompatibility: Material-Mediated PyrogenicityPasses Material-Mediated Pyrogenicity Test per ISO 10993-11, Biological Evaluation of medical devices, Part 11: Test for systemic toxicity. Under the conditions of the study, no pyrogenic response was observed.PASS
    USPEndotoxin TestingMeets acceptance criteria for bacterial endotoxins per USP Bacterial Endotoxins Test. Endotoxin level ≤ 20 EU/device.PASS

    Chemotherapy Drug Permeation Results:

    CompoundMinimum Breakthrough Time (minutes)
    Carmustine (BCNU) (3.3 mg/ml)15.8
    Cyclophosphamide (20 mg/ml)>240
    Doxorubicin (2 mg/ml)>240
    Etoposide (Toposar) (20 mg/ml)>240
    Fluorouracil (50 mg/ml)>240
    Paclitaxel (6 mg/ml)>240
    Thiotepa (THT) (10 mg/ml)24.6
    Bleomycin sulfate (15 mg/ml)>240
    Carboplatin (10 mg/ml)>240
    Cisplatin (1 mg/ml)>240
    Cytarabine (100 mg/ml)>240
    Dacarbazine (10 mg/ml)>240
    Daunorubicin HCl (5 mg/ml)>240
    Docetaxel (10 mg/ml)>240
    Gemcitabine HCl (38 mg/ml)>240
    Idarubicin HCl (1 mg/ml)>240
    Ifosfamide (50 mg/ml)>240
    Irinotecan HCl (20 mg/ml)>240
    Mechlorethamine HCl (1 mg/ml)>240
    Melphalan HCl (5 mg/ml)>240
    Methotrexate (25 mg/ml)>240
    Mitomycin C (0.5 mg/ml)>240
    Mitoxantrone (2 mg/ml)>240
    Vincristine Sulfate (1 mg/ml)>240
    Busulfan (6 mg/ml)>240
    Chloroquine (50 mg/ml)>240
    Cyclosporin A (100 mg/ml)>240
    Epirubicin HCl (2 mg/ml)>240
    Fludarabine Phosphate (25 mg/ml)>240
    Oxaliplatin (2 mg/ml)>240
    Retrovir (10 mg/ml)>240
    Rituximab (10 mg/ml)>240
    Topotecan HCl (1 mg/ml)>240
    Trisenox (Arsenic Trioxide) (1 mg/ml)>240
    Velcade (Bortezomib) (1 mg/ml)>240
    Stomach Acid>240

    Warning: Carmustine: 15.8 minutes and Thiotepa: 24.6 minutes. Do not use with Carmustine and Thiotepa.

    Summary of Study Information (Not Applicable for this Device Type)

    The provided document describes a Class I medical device (Sterile Powder Free Synthetic Rubber Surgeon's Gloves) which is a physical product, not a software device or an AI/ML-driven system. Therefore, the following requested information points related to AI/ML device performance and clinical study methodologies are not applicable. The submission primarily relied on non-clinical (bench) testing to demonstrate substantial equivalence to a predicate device.

    1. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective): Not applicable, as this is a physical device tested via non-clinical laboratory methods according to recognized standards (e.g., ASTM, ISO). The specific sample sizes for each non-clinical test (e.g., number of gloves for tensile strength, number of samples for permeation, number of animals for biocompatibility) are part of the detailed test reports but are not summarized in this FDA summary document. Data provenance details like country of origin for test materials or retrospective/prospective nature are not specified as they are not relevant for this type of non-clinical testing.
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience): Not applicable. "Ground truth" in the context of expert consensus is typically relevant for diagnostic AI/ML devices interpreting medical images or other complex data. For gloves, "ground truth" is established by adherence to quantitative physical, chemical, and biological performance standards.
    3. Adjudication method (e.g. 2+1, 3+1, none) for the test set: Not applicable. Adjudication methods are used in clinical trials or expert review panels, not for standard physical/chemical testing of a device like a glove.
    4. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This device is not an AI system nor does it involve human readers.
    5. If a standalone (i.e. algorithm only without human-in-the loop performance) was done: Not applicable. This device is not an algorithm.
    6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.): For this device, the "ground truth" is adherence to the specified performance criteria defined by the listed consensus standards (e.g., ASTM D3577 for physical properties, ASTM D6978 for chemotherapy permeation, ISO 10993 for biocompatibility). These standards define acceptable quantitative limits or qualitative responses (e.g., "not an irritant").
    7. The sample size for the training set: Not applicable. This device does not involve a "training set" as it is not an AI/ML device.
    8. How the ground truth for the training set was established: Not applicable. This device does not involve a "training set."

    Conclusion:

    The FDA document K250313 confirms the clearance of sterile surgeon's gloves based on their adherence to established non-clinical performance and safety standards, including physical properties, sterility, and resistance to chemotherapy drugs and gastric acid. The document explicitly states that "[a] clinical study was not conducted in support of this submission." The questions related to AI/ML, clinical study designs, expert ground truth, and training data are not relevant to this specific device submission.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 181